Back

What can robust real-world evidence bring to the table?

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Real-world evidence in practice: stroke prevention with non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation Atrial Fibrillation (AF) Open Access ESC Congress 2022

About the speaker

Photo
Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Real-world evidence complements randomised controlled trial data to inform daily clinical practice.
Doctor S. Deitelzweig (New Orleans, US)
Slides Video
Presentation thumbnail
Stroke prevention in sub-populations of patients with non-valvular atrial fibrillation.
Professor G. Lip (Liverpool, GB)
Slides Video
Presentation thumbnail
Audience participation.
Professor G. Lip (Liverpool, GB)
Slides Video

Access the full session

Session thumbnail
Real-world evidence in practice: stroke prevention with non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation
Video

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Comparing the real-world and clinical trial bleeding rates associated with oral anticoagulation treatment for atrial fibrillation
thumbnail
Congress Presentation
Welcome and introduction
thumbnail
Congress Session
The clinical continuum of atrial fibrillation: balancing risks to optimise outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources